| scholarly article | Q13442814 |
| P356 | DOI | 10.2337/DIAB.40.8.971 |
| P698 | PubMed publication ID | 1907250 |
| P2093 | author name string | Stehouwer CD | |
| Mulder PG | |||
| Stroes ES | |||
| Hackeng WH | |||
| Den Ottolander GJ | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic nephropathy | Q1129105 |
| P304 | page(s) | 971-976 | |
| P577 | publication date | 1991-08-01 | |
| P1433 | published in | Diabetes | Q895262 |
| P1476 | title | von Willebrand factor and development of diabetic nephropathy in IDDM. | |
| P478 | volume | 40 |
| Q35106214 | ACE inhibitor intervention in Type 1 diabetes with low grade microalbuminuria |
| Q28354189 | Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function |
| Q36386660 | Association of Haemostatic and Inflammatory Biomarkers with Nephropathy in Type 1 Diabetes Mellitus |
| Q35065524 | Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes |
| Q41184855 | Cerebral blood flow in the diabetic patient |
| Q35941157 | Diet-Induced Podocyte Dysfunction in Drosophila and Mammals |
| Q33739011 | Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study |
| Q71297598 | Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function |
| Q73686588 | Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition |
| Q37806614 | Endothelial dysfunction as a potential contributor in diabetic nephropathy |
| Q33776230 | Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment |
| Q35874337 | Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat |
| Q37251105 | Endothelial-podocyte crosstalk: the missing link between endothelial dysfunction and albuminuria in diabetes |
| Q53085119 | Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. |
| Q41250377 | Hyperinsulinaemia, insulin resistance, microalbuminuria and the risk of coronary heart disease |
| Q35989396 | Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. |
| Q33786866 | Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications |
| Q41740391 | Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction? |
| Q48561405 | Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005. |
| Q39222822 | Suboptimal glycaemic control enhances the risk of impaired prothrombotic state in youths with type 1 diabetes mellitus |
| Q36892489 | Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. |
| Q33283202 | Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes |
| Q89837558 | Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes |
| Q35689644 | Von Willebrand Factor, ADAMTS13 and D-Dimer Are Correlated with Different Levels of Nephropathy in Type 1 Diabetes Mellitus |
| Q44752243 | von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion |
Search more.